Associations of ECG Signs of Ischemic and Non-Specific Signs of Metabolic Changes in the Myocardium With Unfavorable Cardiovascular Prognosis in a 7-Year Prospective Follow-Up of Young People Under 45 Years

Aim. To study ischemic and/or nonspecific ECG signs of metabolic changes in the myocardium and to determine their relationship with unfavorable cardiovascular prognosis in a 7-year prospective observation of young people under 45 years of age.
Material and methods. A cross-sectional population survey of a random sample aged 25-44 years (n=1363) was conducted in Novosibirsk. The survey program used the standardized epidemiological Rose questionnaire. Biochemical tests were used to measure blood concentrations of total cholesterol (C), triglycerides (TG), low- and high-density lipoprotein cholesterol (LDL-C, HDL-C), and fasting blood plasma glucose. Systolic and diastolic BP (SBP, DBP), the presence of arterial hypertension (AH), body mass index (BMI), waist circumference (WC), and smoking status were assessed. ECG was recorded at rest in 12 standard leads followed by interpretation according to the Minnesota Code. The presence of ischemic and/or nonspecific ECG signs of metabolic changes in the myocardium was determined. Subjects with ECG signs of ischemic changes in the myocardium were selected for long-term follow-up and additional examination by cardiologists. Then the whole cohort was monitored for 7 years, and cardiovascular events were recorded, including using data from the WHO Myocardial Infarction Registry in Novosibirsk. For statistical analysis of the results, cardiovascular events were combined into a composite endpoint.
Results. During 7 years, 40 people (27 men and 13 women) had an unfavorable cardiovascular prognosis. Multivariate regression analysis showed that a 7-year unfavorable cardiovascular prognosis in people younger than 45 years was associated with signs of ischemic myocardial alterations identified on the background ECG (OR 5.319, 95% CI: 1.543-18.342, p=0.008) and nonspecific ECG signs of metabolic changes in the myocardium (OR 2.978, 95% CI: 1.216-7.216, p=0.017) regardless of age, gender, the presence of arterial hypertension (AH) and type 2 diabetes mellitus (DM2).
Conclusion. In young people under 45 years of age, not only ECG signs of ischemic changes in the myocardium, but also nonspecific ECG signs of metabolic changes in the myocardium are associated with an unfavorable cardiovascular prognosis, directly and independently on age and gender, in a long-term, 7-year period.

1. Vilkov V.G., Shalnova S.A. Thirty-year trends in the prevalence of cardiometabolic risk factors in the populations of the Russian Federation and the United States of America. Cardiovascular Therapy and Prevention. 2022;21(8):34–9. DOI: 10.15829/1728-8800-2022-3304

2. Shukor MFA, Musthafa QA, Mohd Yusof YA, Wan Ngah WZ, Ismail NAS. Biomarkers for Premature Coronary Artery Disease (PCAD): A Case Control Study. Diagnostics. 2023;13(2):188. DOI: 10.3390/diagnostics13020188

3. Jahangiry L, Abbasalizad Farhangi M, Najafi M, Sarbakhsh P. Clusters of the Risk Markers and the Pattern of Premature Coronary Heart Disease: An Application of the Latent Class Analysis. Frontiers in Cardiovascular Medicine. 2021;8:707070. DOI: 10.3389/fcvm.2021.707070

4. Babahajiani M, Zarepur E, Khosravi A, Mohammadifard N, Noohi F, Alikhasi H et al. Ethnic differences in the lifestyle behaviors and premature coronary artery disease: a multi-center study. BMC Cardiovascular Disorders. 2023;23(1):170. DOI: 10.1186/s12872-023-03192-0

5. Andreenko E.Yu., Yavelov I.S., Loukianov M.M., Vernohaeva A.N., Drapkina O.M., Boytsov S.A. Ischemic Heart Disease in Subjects of Young Age: Current State of the Problem: Prevalence and Cardiovascular Risk Factors. Kardiologiia. 2018;58(10):53–8. DOI: 10.18087/cardio.2018.10.10184

6. Muromtseva G.A., Vilkov V.G., Konstantinov V.V., Deev A.D., Oshchepkova E.V., Rotar O.P. et al. The prevalence of electrocardiographic abnormalities in the Russian population in the early 21st century (the ESSE-RF study). Russian Journal of Cardiology. 2018;23(12):7–17. DOI: 10.15829/1560-4071-2018-12-7-17

7. Kalinina A.M., Shalnova S.A., Gambaryan M.G., Eganyan R.A., Muromtseva G.A., Bochkareva E.V. et al. Epidemiological methods for identifying the main chronic non-communicable diseases and risk factors during mass population surveys. Methodical guide. Edited by Prof. Boytsov S.A. - M.: GNICPM; 2015. - 96p. Av. at: https://gnicpm.ru/wp-content/uploads/2020/01/metodposobie_epid_metody_viyavleniya_hniz_pri_massovih_obsledovaniyah.pdf.

8. Antropova O.N., Silkina S.B., Polyakova I.G., Perevozchikova T.V. Association of hemodynamic parameters and cardiovascular risk factors with cardiac remodeling in young patients with prehypertension and hypertension. Russian Journal of Cardiology. 2020;25(6):73– 8. DOI: 10.15829/1560-4071-2020-3797

9. Bogatyreva F.M., Kaplunova V.Yu., Kozhevnikova M.V., Shakaryant s G.A., Privalova E.V., Belenkov Yu.N. Correlation between markers of fibrosis and myocardial remodeling in patients with various course of hypertrophic cardiomyopathy. Cardiovascular Therapy and Prevention. 2022;21(3):28–35. DOI: 10.15829/1728-8800-2022-3140

10. Shishkova V.N., Martynov A.I. Insulin resistance: focus on the pathogenesis of cardiomyopathy. Consilium Medicum. 2020;22(10):52–4. [Russian: Шишкова В.Н., Мартынов А.И. Инсулинорезистентность: фокус на патогенез кардиомиопатии. Consilium Medicum. 2020;22(10):52–4]. DOI: 10.26442/20751753.2020.10.200341

11. Karavaev P.G., Veklich A.S., Koziolova N.A. Cardiovascular remodeling in patients with diabetic сardiomyopathy. Russian Journal of Cardiology. 2019;24(11):42–7. DOI: 10.15829/1560-4071-2019-11-42-47

12. Timoshenko N.A., Ragino Yu.I., Voevoda M.I. Metabolic cardiomyopathy. Current state of problem. Ateroscleroz. 2013;9(1):65–76.

13. Kuzminykh N.A., Shcherbakova L.V., Shramko V.S., Denisova D.V., Ragi no Yu.I. Associations of cardiovascular disease risk factors with electrophysiological signs of myocardial metabolic disorders in young people 25—44 years old. Prevention Medicine. 2021;24(12):49–56. DOI: 10.17116/profmed20212412149

14. Zhang Z, Prineas RJ, Soliman EZ, Baggett C, Heiss G, (for the ARIC Research Group). Prognostic significance of serial Q/ST-T changes by the Minnesota Code and Novacode in the Atherosclerosis Risk in Communities (ARIC) study. European Journal of Preventive Cardiology. 2012;19(6):1430–6. DOI: 10.1177/1741826711426091

15. Ricardo Pires J, Teixeira M, Ferreira F, Viseu I, Afreixo V, Neves C. Electrocardiography in Hypertensive Patients without Cardiovascular Events: A Valuable Predictor Tool? International Journal of Hypertension. 2022;2022:7038894. DOI: 10.1155/2022/7038894

16. Niu J, Deng C, Zheng R, Xu M, Lu J, Wang T et al. The Association and Predictive Ability of ECG Abnormalities with Cardiovascular Diseases: A Prospective Analysis. Global Heart. 2020;15(1):59. DOI: 10.5334/gh.790

17. Krittayaphong R, Muenkaew M, Chiewvit P, Ratanasit N, Kaolawanich Y, Phrommintikul A et al. Electrocardiographic predictors of cardiovascular events in patients at high cardiovascular risk: a multicenter study. Journal of Geriatric Cardiology. 2019;16(8):630–8. DOI: 10.11909/j.issn.1671-5411.2019.08.004

18. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290(1):140–205. DOI: 10.1016/j.atherosclerosis.2019.08.014

19. Auer R, Bauer DC, Marques-Vidal P, Butler J, Min LJ, Cornuz J et al. Association of Major and Minor ECG Abnormalities With Coronary Heart Disease Events. JAMA. 2012;307(14):1497–505. DOI: 10.1001/jama.2012.434

20. Novo S, Diana D, Tomasino C, Zambelli G, Mignano A, Scalmato A et al. Electrocardiographic abnormalities, preclinical carotid atherosclerosis and cardiovascular risk in an apparently healthy real-world population. Data from the ‘No Stroke, No Infarction’ project of the Rotary International - district 2110 (Sicily and Malta). International Angiology. 2021;40(6):470–7. DOI: 10.23736/S0392-9590.21.04637-X

21. Shin J, Lee Y, Park J-K, Shin J-H, Lim Y-H, Ran H et al. Prognostic value of myocardial injury-related findings on resting electrocardiography for cardiovascular risk in the asymptomatic general population: the 12-year follow-up report from the Ansan-Ansung cohort. Annals of Medicine. 2020;52(5):215–24. DOI: 10.1080/07853890.2020.1755052